TVM Life Science Ventures VII L.P.'s Net Worth
$59 Million
Who is TVM Life Science Ventures VII L.P.?
TVM Life Science Ventures VII L.P. has an estimated net worth of $59 Million. This is based on reported shares across multiple companies, which include CoLucid Pharmaceuticals, Inc., and Acer Therapeutics Inc..
SEC CIK
TVM Life Science Ventures VII L.P.'s CIK is 0001640880
Past Insider Trading and Trends
2017 was TVM Life Science Ventures VII L.P.'s most active year for acquiring shares with 6 total transactions. TVM Life Science Ventures VII L.P.'s most active month to acquire stocks was the month of April. 2017 was TVM Life Science Ventures VII L.P.'s most active year for disposing of shares, totalling 6 transactions. TVM Life Science Ventures VII L.P.'s most active month to dispose stocks was the month of February. 2015 saw TVM Life Science Ventures VII L.P. paying a total of $5,000,000.00 for 2,496,726 shares, this is the most they've acquired in one year. In 2017 TVM Life Science Ventures VII L.P. cashed out on 1,564,715 shares for a total of $72,585,245.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CoLucid Pharmaceuticals, Inc. No price found
InvestorTVM Life Science Ventures VII L.P. used to own units in Common Stock but no longer holds any shares there. From 2015 to 2017 TVM Life Science Ventures VII L.P. acquired a total of 1,495,386 shares in CoLucid Pharmaceuticals, Inc. at a cost of $5,000,000.00, TVM also disposed a total of 1,545,386 shares of CoLucid Pharmaceuticals, Inc. equalling to $71,860,449.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.55M |
$46.50 | -$71,860,449.00 |
0
|
Mar 1
| |||
Form 4
|
∞
| 1.5M |
$10.00 |
—
| 1.5M |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12 - May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Acer Therapeutics Inc. (ACER) Snapshot price: $0.6601
InvestorTVM Life Science Ventures VII L.P. owns 1,697,709 units of Common Stock which is worth $1,120,657.71. In the year 2017 TVM Life Science Ventures VII L.P. acquired a total of 2,672,309 shares in Acer Therapeutics Inc. at a cost of $8,949,996.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.33% | 275K |
$18.00 | $4,950,000.00 | 1.7M |
Aug 1
| |||
Form 4
| +16.15% | 333.33K |
$12.00 | $3,999,996.00 | 2.4M |
Dec 12
| |||
Form 4
|
∞
| 2.06M |
—
|
—
| 2.06M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |